Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 5
2006 2
2007 4
2008 6
2009 7
2010 6
2011 4
2012 7
2013 5
2014 2
2015 4
2016 10
2017 8
2018 4
2019 8
2020 30
2021 32
2022 22
2023 23
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.
Rivellese F, Surace AEA, Goldmann K, Sciacca E, Çubuk C, Giorli G, John CR, Nerviani A, Fossati-Jimack L, Thorborn G, Ahmed M, Prediletto E, Church SE, Hudson BM, Warren SE, McKeigue PM, Humby F, Bombardieri M, Barnes MR, Lewis MJ, Pitzalis C; R4RA collaborative group. Rivellese F, et al. Nat Med. 2022 Jun;28(6):1256-1268. doi: 10.1038/s41591-022-01789-0. Epub 2022 May 19. Nat Med. 2022. PMID: 35589854 Free PMC article. Clinical Trial.
Lessons from the Italian COVID-19 frontline.
Bellan M, Sainaghi PP, Gavelli F, Patrucco F, Avanzi GC, Pirisi M, Castello LM. Bellan M, et al. Among authors: sainaghi pp. Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1. Minerva Med. 2020. PMID: 33032392 Free article. No abstract available.
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, Nerviani A, Giorli G, Mahto A, Montecucco C, Lauwerys B, Ng N, Ho P, Bombardieri M, Romão VC, Verschueren P, Kelly S, Sainaghi PP, Gendi N, Dasgupta B, Cauli A, Reynolds P, Cañete JD, Moots R, Taylor PC, Edwards CJ, Isaacs J, Sasieni P, Choy E, Pitzalis C; R4RA collaborative group. Humby F, et al. Among authors: sainaghi pp. Lancet. 2021 Jan 23;397(10271):305-317. doi: 10.1016/S0140-6736(20)32341-2. Lancet. 2021. PMID: 33485455 Free PMC article. Clinical Trial.
Use, misuse and abuse of diuretics.
Bartoli E, Rossi L, Sola D, Castello L, Sainaghi PP, Smirne C. Bartoli E, et al. Among authors: sainaghi pp. Eur J Intern Med. 2017 Apr;39:9-17. doi: 10.1016/j.ejim.2017.01.016. Epub 2017 Feb 21. Eur J Intern Med. 2017. PMID: 28233622 Review.
The Gas6/TAM System and Multiple Sclerosis.
Bellan M, Pirisi M, Sainaghi PP. Bellan M, et al. Among authors: sainaghi pp. Int J Mol Sci. 2016 Oct 28;17(11):1807. doi: 10.3390/ijms17111807. Int J Mol Sci. 2016. PMID: 27801848 Free PMC article. Review.
Role of Vitamin D in Rheumatoid Arthritis.
Bellan M, Sainaghi PP, Pirisi M. Bellan M, et al. Among authors: sainaghi pp. Adv Exp Med Biol. 2017;996:155-168. doi: 10.1007/978-3-319-56017-5_13. Adv Exp Med Biol. 2017. PMID: 29124698 Review.
Overlapping polyclonal lymphoproliferative disorders.
Bonometti R, Bellan M, Sola D, Gibbin A, Gavelli F, Patrucco F, Spina P, Gualerzi A, Favretto S, Castello LM, Sainaghi PP, Pirisi M. Bonometti R, et al. Among authors: sainaghi pp. Natl Med J India. 2020 Nov-Dec;33(6):344-346. doi: 10.4103/0970-258X.321144. Natl Med J India. 2020. PMID: 34341211
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Understanding protection from SARS-CoV-2 using metabolomics.
Barberis E, Amede E, Tavecchia M, Marengo E, Cittone MG, Rizzi E, Pedrinelli AR, Tonello S, Minisini R, Pirisi M, Manfredi M, Sainaghi PP. Barberis E, et al. Among authors: sainaghi pp. Sci Rep. 2021 Jul 5;11(1):13796. doi: 10.1038/s41598-021-93260-2. Sci Rep. 2021. PMID: 34226622 Free PMC article.
177 results